Clinical Trial Update: Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease [EARLY_Phase 1]

View source ↗

Summary

Update on an early-phase trial of anti-CD19/BCMA CAR-NK cells for B cell–mediated autoimmune diseases, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy
• Multidrug-resistant Nephrotic Syndrome
• Systemic Lupus Erythematosus

Drugs mentioned

• Anti-CD19/BCMA CAR-NK cells

Snippet

Sponsor: The Children's Hospital of Zhejiang University School of Medicine | Conditions: Autoimmune Diseases, Systemic Lupus Erthematosus | EARLY_Phase 1 | Status: RECRUITING